ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Type A Meeting with FDA
|
|
irenekwshiu
|
574 |
197K |
28 |
22/09/23 |
22/09/23 |
ASX - By Stock
|
574
|
197K
|
28
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Type A Meeting with FDA
|
|
irenekwshiu
|
574 |
197K |
36 |
22/09/23 |
22/09/23 |
ASX - By Stock
|
574
|
197K
|
36
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Type A Meeting with FDA
|
|
irenekwshiu
|
574 |
197K |
7 |
21/09/23 |
21/09/23 |
ASX - By Stock
|
574
|
197K
|
7
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Type A Meeting with FDA
|
|
irenekwshiu
|
574 |
197K |
9 |
21/09/23 |
21/09/23 |
ASX - By Stock
|
574
|
197K
|
9
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Type A Meeting with FDA
|
|
irenekwshiu
|
574 |
197K |
17 |
21/09/23 |
21/09/23 |
ASX - By Stock
|
574
|
197K
|
17
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Update on BLA for Graft Versus Host Disease
|
|
irenekwshiu
|
1.0K |
399K |
12 |
17/09/23 |
17/09/23 |
ASX - By Stock
|
1.0K
|
399K
|
12
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
irenekwshiu
|
17K |
6.7M |
6 |
16/09/23 |
16/09/23 |
ASX - By Stock
|
17K
|
6.7M
|
6
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
irenekwshiu
|
9.9K |
3.0M |
1 |
15/09/23 |
15/09/23 |
ASX - By Stock
|
9.9K
|
3.0M
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Ann: MSB Reports Q3 Financial Results and Operational Highlights
|
|
irenekwshiu
|
362 |
114K |
6 |
15/09/23 |
15/09/23 |
ASX - By Stock
|
362
|
114K
|
6
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
irenekwshiu
|
9.9K |
3.0M |
2 |
01/09/23 |
01/09/23 |
ASX - By Stock
|
9.9K
|
3.0M
|
2
|
|
ASX - By Stock
|
MSB |
Re:
2023 The Final Countdown
|
|
irenekwshiu
|
3.4K |
1.2M |
4 |
31/08/23 |
31/08/23 |
ASX - By Stock
|
3.4K
|
1.2M
|
4
|
|
ASX - By Stock
|
MSB |
Re:
2023 The Final Countdown
|
|
irenekwshiu
|
3.4K |
1.2M |
5 |
31/08/23 |
31/08/23 |
ASX - By Stock
|
3.4K
|
1.2M
|
5
|
|
ASX - By Stock
|
MSB |
Re:
Mesoblast CC Transcript 31/8
|
|
irenekwshiu
|
73 |
30K |
5 |
31/08/23 |
31/08/23 |
ASX - By Stock
|
73
|
30K
|
5
|
|
ASX - By Stock
|
MSB |
Re:
CEO Itescu needs to go
|
|
irenekwshiu
|
907 |
285K |
2 |
30/08/23 |
30/08/23 |
ASX - By Stock
|
907
|
285K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
2023 Next Steps
|
|
irenekwshiu
|
165 |
67K |
10 |
29/08/23 |
29/08/23 |
ASX - By Stock
|
165
|
67K
|
10
|
|
ASX - By Stock
|
MSB |
Re:
CEO Itescu needs to go
|
|
irenekwshiu
|
907 |
285K |
9 |
28/08/23 |
28/08/23 |
ASX - By Stock
|
907
|
285K
|
9
|
|
ASX - By Stock
|
MSB |
Re:
CEO Itescu needs to go
|
|
irenekwshiu
|
907 |
285K |
16 |
26/08/23 |
26/08/23 |
ASX - By Stock
|
907
|
285K
|
16
|
|
ASX - By Stock
|
MSB |
Re:
CEO Itescu needs to go
|
|
irenekwshiu
|
907 |
285K |
15 |
24/08/23 |
24/08/23 |
ASX - By Stock
|
907
|
285K
|
15
|
|
ASX - By Stock
|
MSB |
Re:
2023 Next Steps
|
|
irenekwshiu
|
165 |
67K |
4 |
24/08/23 |
24/08/23 |
ASX - By Stock
|
165
|
67K
|
4
|
|
ASX - By Stock
|
MSB |
Re:
CEO Itescu needs to go
|
|
irenekwshiu
|
907 |
285K |
18 |
24/08/23 |
24/08/23 |
ASX - By Stock
|
907
|
285K
|
18
|
|
ASX - By Stock
|
MSB |
Re:
CEO Itescu needs to go
|
|
irenekwshiu
|
907 |
285K |
15 |
24/08/23 |
24/08/23 |
ASX - By Stock
|
907
|
285K
|
15
|
|
ASX - By Stock
|
MSB |
Re:
CEO Itescu needs to go
|
|
irenekwshiu
|
907 |
285K |
4 |
19/08/23 |
19/08/23 |
ASX - By Stock
|
907
|
285K
|
4
|
|
ASX - By Stock
|
MSB |
Re:
CEO Itescu needs to go
|
|
irenekwshiu
|
907 |
285K |
0 |
19/08/23 |
19/08/23 |
ASX - By Stock
|
907
|
285K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
CEO Itescu needs to go
|
|
irenekwshiu
|
907 |
285K |
12 |
19/08/23 |
19/08/23 |
ASX - By Stock
|
907
|
285K
|
12
|
|
ASX - By Stock
|
MSB |
Re:
CEO Itescu needs to go
|
|
irenekwshiu
|
907 |
285K |
6 |
18/08/23 |
18/08/23 |
ASX - By Stock
|
907
|
285K
|
6
|
|
ASX - By Stock
|
MSB |
Re:
Short position- MSB 3rd most heavily shorted ASX o share
|
|
irenekwshiu
|
29 |
12K |
0 |
01/02/21 |
01/02/21 |
ASX - By Stock
|
29
|
12K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Remestemcel-L FDA Fast Track Designation for COVID-19 ARDS
|
|
irenekwshiu
|
572 |
252K |
10 |
16/01/21 |
16/01/21 |
ASX - By Stock
|
572
|
252K
|
10
|
|